Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer A. Jo ChienHope S. Rugo Review Open access 10 November 2012 Pages: 1 - 12
The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis Su-Ying FangBih-Ching ShuYing-Ju Chang Review 06 December 2012 Pages: 13 - 21
Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer L. Susan TaichmanAaron M. HavensCatherine H. Van Poznak Invited Review 18 September 2012 Pages: 23 - 32
Cognitive function and breast cancer: promise and potential insights from functional brain imaging Patricia A. Reuter-LorenzBernadine Cimprich Invited Review 09 October 2012 Pages: 33 - 43
Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease Chidananda M. SiddappaMark A. WatsonRebecca Aft Preclinical Study 06 November 2012 Pages: 45 - 56
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer Karin Milde-LangoschThomas KarnRalph M. Wirtz Preclinical Study 08 November 2012 Pages: 57 - 67
Prospective dual role of mesenchymal stem cells in breast tumor microenvironment Christiane SenstTimo Nazari-ShaftiReza Izadpanah Preclinical Study 10 November 2012 Pages: 69 - 79
Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation Niladri ChattopadhyayZhongli CaiRaymond M. Reilly Preclinical study 18 November 2012 Pages: 81 - 91
Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat) Makoto KuboNoriko KanayaShiuan Chen Preclinical study 18 November 2012 Pages: 93 - 107
Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells Herbert FluhrTina SeitzMarek Zygmunt Preclinical Study 18 November 2012 Pages: 109 - 118
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer Seth RummelErika VarnerRachel E. Ellsworth Preclinical study 29 November 2012 Pages: 119 - 125
Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer B. G. BakerG. R. BallA. R. Green Preclinical Study 04 December 2012 Pages: 127 - 137
The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients Sarkawt M. KhoshnawEmad A. RakhaAndrew R. Green Preclinical study 06 December 2012 Pages: 139 - 153
Diffuse reflectance spectroscopy: towards clinical application in breast cancer Daniel J. EversRami NachabeTheo J. M. Ruers Preclinical study 06 December 2012 Pages: 155 - 165
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole G. LunardiP. PiccioliL. Del Mastro Clinical Trial Open access 06 November 2012 Pages: 167 - 174
Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer Sandra C. HayesSheree RyeElizabeth Eakin Clinical Trial 09 November 2012 Pages: 175 - 186
A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer Gilberto LopesStefan GlückAlberto J. Montero Clinical trial 11 November 2012 Pages: 187 - 193
Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy Na Rae JuDonna B. JeffeRebecca Aft Clinical trial 13 November 2012 Pages: 195 - 201
Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer Nobuaki MatsubaraHirofumi MukaiNoriaki Wada Clinical trial 27 November 2012 Pages: 203 - 212
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer Jorma J. de RondeEsther H. LipsLodewyk F. A. Wessels Clinical trial 01 December 2012 Pages: 213 - 223
Dual association between polyphenol intake and breast cancer risk according to alcohol consumption level: a prospective cohort study Mathilde TouvierNathalie Druesne-PecolloPaule Latino-Martel Epidemiology 07 November 2012 Pages: 225 - 236
Hypothesized role of pregnancy hormones on HER2+ breast tumor development Giovanna I. CruzMaría Elena MartínezPatricia A. Thompson Epidemiology 08 November 2012 Pages: 237 - 246
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004–2007 Allison W. KurianDaphne Y. LichtensztajnScarlett L. Gomez Epidemiology 09 November 2012 Pages: 247 - 260
Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) Study Candyce H. KroenkeCharles QuesenberryBette J. Caan Epidemiology 10 November 2012 Pages: 261 - 271
The association of breast density with breast cancer mortality in African American and white women screened in community practice Shengfan ZhangJulie S. IvyBonnie C. Yankaskas Epidemiology 10 November 2012 Pages: 273 - 283
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004–2010 Stacie B. DusetzinaG. Caleb AlexanderNancy L. Keating Epidemiology 13 November 2012 Pages: 285 - 296
Placental weight and mortality in premenopausal breast cancer by tumor characteristics Mohammad Hossein HajiebrahimiShahram BahmanyarSven Cnattingius Epidemiology 13 November 2012 Pages: 297 - 305
Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis Mariaelena PierobonCara L. Frankenfeld Epidemiology 20 November 2012 Pages: 307 - 314
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers Emanuele MazzolaSu-Chun ChengGiovanni Parmigiani Brief Report 27 November 2012 Pages: 315 - 318
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients Ashley M. HolderAna M. Gonzalez-AnguloFunda Meric-Bernstam Brief Report 04 December 2012 Pages: 319 - 327
